13 October 2023>: Clinical Research
Rising Drug Resistance Among Gram-Negative Pathogens in Bloodstream Infections: A Multicenter Study in Ulanhot, Inner Mongolia (2017–2021)
Yinxia Feng 1AE* , Zhijun Wang 1B* , Zelin Hao 2C , Jinlong Du 3D , Hui Jiang 1F*DOI: 10.12659/MSM.940686
Med Sci Monit 2023; 29:e940686
Table 7 Resistance rates of Pseudomonas aeruginosa to antibiotics.
Anti-bacterial agent | 2017 (n=164) | 2018 (n=186) | 2019 (n=201) | 2020 (n=134) | 2021 (n=193) | χ2 | P value |
---|---|---|---|---|---|---|---|
Aztreonam | 12.28 | 22.37 | 28.13 | 17.58 | 21.56 | 0.746 | 0.984 |
Imipenem | 12.64 | 20.45 | 20.94 | 19.52 | 19.46 | 0.539 | 1.000 |
Ceftazidime | 16.92 | 14.37 | 17.65 | 14.67 | 18.56 | 0.865 | 0.968 |
Levofloxacin | 13.27 | 22.31 | 13.64 | 13.26 | 14.62 | 1.115 | 0.920 |
Piperacillin | 15.26 | 17.48 | 14.71 | 11.24 | 16.11 | 0.592 | 1.000 |
Ciprofloxacin | 10.62 | 9.75 | 9.42 | 9.94 | 10.47 | 0.880 | 1.000 |
Meropenem | 11.23 | 14.48 | 14.46 | 8.46 | 9.57 | 0.946 | 0.980 |
Cefepime | 6.38 | 11.34 | 11.35 | 4.59 | 8.16 | 1.383 | 0.967 |
Piperacillin/tazobactam | 3.25 | 10.73 | 10.72 | 7.95 | 9.37 | 2.118 | 0.808 |
Gentamicin | 8.56 | 10.24 | 10.16 | 4.73 | 5.74 | 1.383 | 0.967 |
Amifloxacin | 8.42 | 7.28 | 3.98 | 1.46 | 2.13 | 2.009 | 0.901 |
Data are presented as percentage rate (%). |